Bioequivalence Study of Modified-Release Gliclazide Tablets in Healthy Volunteers

Table 1

Demographic characteristics of the volunteers administered with 30 mg gliclazide MR tablets.

Demographic characteristic	Group number 1	Group number 2
Age (y)	29 ± 6.28	28.22 ± 7.33
Height (m)	1.72 ± 0.04	1.67 ± 0.02
Weight (kg)	65.70 ± 5.11	62.80 ± 4.70
Body mass index (kg/m^2)	22.25 ± 1.62	22.52 ± 1.77